Viewing Study NCT01234558


Ignite Creation Date: 2025-12-25 @ 12:10 AM
Ignite Modification Date: 2026-01-27 @ 5:27 AM
Study NCT ID: NCT01234558
Status: COMPLETED
Last Update Posted: 2012-09-12
First Post: 2010-11-03
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Single IV Dose of GLYX-13 in Patients With Treatment-Resistant Depression
Sponsor: Naurex, Inc, an affiliate of Allergan plc
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Major Depressive Disorder View
Keywords:

Keywords

Keyword Brief Keyword Text View
None depression View
None NMDA antagonist View
None treatment resistant View